![Gordon Naylor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gordon Naylor
Vorstandsvorsitzender bei
CSL LIMITED
Vermögen: 4 Mio $ am 30.06.2026
Profil
Gordon Naylor is Chief Executive Officer, MD & Director at CSL Ltd. since 2026.
Mr. Naylor is Independent Non-Executive Director at Orica Ltd. since 2022.
Mr. Naylor is Director at Seqirus Holdings UK Ltd. since 2015.
Mr. Naylor is Senior Vice President & General Manager at CSL Plasma, Inc. Former roles include Non-Executive Chairman at Medical Developments International Ltd. from 2020 to 2025, Chief Financial Officer at CSL Ltd. from 2010 to 2016, EVP-Plasma, Supply Chain & Information Systems at CSL Behring LLC, and President at Seqirus UK Ltd. from 2015 to 2019.
Education includes an MBA from Melbourne Business School and undergraduate studies at the University of Melbourne.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CSL LIMITED 0.01% | 26.05.2026 | 40’819 ( 0.01% ) | 3 Mio $ | 30.06.2026 |
| 15.08.2025 | 1’045’113 ( 0.93% ) | 286 006 $ | 30.06.2026 | |
| 30.09.2025 | 16’394 ( 0% ) | 268 952 $ | 30.06.2026 |
Aktive Positionen von Gordon Naylor
| Unternehmen | Position | Beginn |
|---|---|---|
| ORICA LIMITED | Direktor/Vorstandsmitglied | 01.04.2022 |
| CSL LIMITED | Vorstandsvorsitzender | 11.02.2026 |
CSL Plasma, Inc.
 CSL Plasma, Inc. Medical/Nursing ServicesHealth Services Collects blood donations | Corporate Officer/Principal | - |
Seqirus Holdings UK Ltd.
 Seqirus Holdings UK Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direktor/Vorstandsmitglied | 29.05.2015 |
Ehemalige bekannte Positionen von Gordon Naylor
| Unternehmen | Position | Ende |
|---|---|---|
| MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Vorsitzender | 01.12.2025 |
Seqirus UK Ltd.
 Seqirus UK Ltd. Pharmaceuticals: MajorHealth Technology Develops and delivers therapies for people living with conditions in the immunology, hematology, cardiovascular, metabolic, respiratory & transplant therapeutic areas | Präsident | 01.06.2019 |
| CSL LIMITED | Finanzdirektor/CFO | 02.01.2016 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Finanzdirektor/CFO | - |
Ausbildung von Gordon Naylor
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
50
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Medical Developments International Ltd.
 Medical Developments International Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical drugs & medical equipment | Health Technology |
Melbourne Business School
 Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orica Ltd.
 Orica Ltd. Industrial SpecialtiesProcess Industries Manufactures and distributes commercial blasting systems & mining and tunneling support systems to the mining and infrastructure markets | Process Industries |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
CSL Plasma, Inc.
CSL Plasma, Inc. Medical/Nursing ServicesHealth Services Collects blood donations | Health Services |
Seqirus UK Ltd.
Seqirus UK Ltd. Pharmaceuticals: MajorHealth Technology Develops and delivers therapies for people living with conditions in the immunology, hematology, cardiovascular, metabolic, respiratory & transplant therapeutic areas | Health Technology |
Seqirus Holdings UK Ltd.
Seqirus Holdings UK Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
